These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14671208)

  • 21. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
    Halabi-Tawil M; Ruemmele FM; Fraitag S; Rieux-Laucat F; Neven B; Brousse N; De Prost Y; Fischer A; Goulet O; Bodemer C
    Br J Dermatol; 2009 Mar; 160(3):645-51. PubMed ID: 18795917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXP3 acts as a rheostat of the immune response.
    Ochs HD; Ziegler SF; Torgerson TR
    Immunol Rev; 2005 Feb; 203():156-64. PubMed ID: 15661028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis.
    Gambineri E; Torgerson TR; Ochs HD
    Curr Opin Rheumatol; 2003 Jul; 15(4):430-5. PubMed ID: 12819471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome.
    Blanco Quirós A; Arranz Sanz E; Bernardo Ordiz D; Garrote Adrados JA
    Allergol Immunopathol (Madr); 2009; 37(4):208-15. PubMed ID: 19912978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review.
    Park JH; Lee KH; Jeon B; Ochs HD; Lee JS; Gee HY; Seo S; Geum D; Piccirillo CA; Eisenhut M; van der Vliet HJ; Lee JM; Kronbichler A; Ko Y; Shin JI
    Autoimmun Rev; 2020 Jun; 19(6):102526. PubMed ID: 32234571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome.
    Zhan H; Sinclair J; Adams S; Cale CM; Murch S; Perroni L; Davies G; Amrolia P; Qasim W
    Pediatrics; 2008 Apr; 121(4):e998-1002. PubMed ID: 18316354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel variant of FOXP3 resulting in severe immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome highlights potential pitfalls of molecular testing.
    Kirchner A; Sanchez IM; Zalan A; Bhat G; Bain M
    Pediatr Dermatol; 2022 May; 39(3):483-485. PubMed ID: 35191551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in two cases].
    Zhu Q; Yuan K; Wang C; Fang Y; Zhu J; Liang L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):389-392. PubMed ID: 29896738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXP3 deficiency, from the mechanisms of the disease to curative strategies.
    Borna S; Meffre E; Bacchetta R
    Immunol Rev; 2024 Mar; 322(1):244-258. PubMed ID: 37994657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of the skin lesions in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
    Martín-Santiago A; Hervás JA; Hervás D; Rosell A; Caimari M; de Carlos JC; Matamoros N
    Pediatr Dermatol; 2013; 30(6):e221-2. PubMed ID: 23534934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potential screening tool for IPEX syndrome.
    Heltzer ML; Choi JK; Ochs HD; Sullivan KE; Torgerson TR; Ernst LM
    Pediatr Dev Pathol; 2007; 10(2):98-105. PubMed ID: 17378693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation.
    Baud O; Goulet O; Canioni D; Le Deist F; Radford I; Rieu D; Dupuis-Girod S; Cerf-Bensussan N; Cavazzana-Calvo M; Brousse N; Fischer A; Casanova JL
    N Engl J Med; 2001 Jun; 344(23):1758-62. PubMed ID: 11396442
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3.
    Kobayashi I; Kubota M; Yamada M; Tanaka H; Itoh S; Sasahara Y; Whitesell L; Ariga T
    Clin Immunol; 2011 Oct; 141(1):83-9. PubMed ID: 21741320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation.
    Baris S; Schulze I; Ozen A; Karakoç Aydıner E; Altuncu E; Karasu GT; Ozturk N; Lorenz M; Schwarz K; Vraetz T; Ehl S; Barlan IB
    J Clin Immunol; 2014 Aug; 34(6):601-6. PubMed ID: 24916357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome.
    d'Hennezel E; Ben-Shoshan M; Ochs HD; Torgerson TR; Russell LJ; Lejtenyi C; Noya FJ; Jabado N; Mazer B; Piccirillo CA
    N Engl J Med; 2009 Oct; 361(17):1710-3. PubMed ID: 19846862
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
    Otsubo K; Kanegane H; Kamachi Y; Kobayashi I; Tsuge I; Imaizumi M; Sasahara Y; Hayakawa A; Nozu K; Iijima K; Ito S; Horikawa R; Nagai Y; Takatsu K; Mori H; Ochs HD; Miyawaki T
    Clin Immunol; 2011 Oct; 141(1):111-20. PubMed ID: 21802372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, Immunological, and Genetic Features in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) and IPEX-like Syndrome.
    Jamee M; Zaki-Dizaji M; Lo B; Abolhassani H; Aghamahdi F; Mosavian M; Nademi Z; Mohammadi H; Jadidi-Niaragh F; Rojas M; Anaya JM; Azizi G
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2747-2760.e7. PubMed ID: 32428713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
    Nieves DS; Phipps RP; Pollock SJ; Ochs HD; Zhu Q; Scott GA; Ryan CK; Kobayashi I; Rossi TM; Goldsmith LA
    Arch Dermatol; 2004 Apr; 140(4):466-72. PubMed ID: 15096376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual and early onset IPEX syndrome: a case report.
    Doğruel D; Gürbüz F; Turan İ; Altıntaş DU; Yılmaz M; Yüksel B
    Turk J Pediatr; 2019; 61(4):580-584. PubMed ID: 31990476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea.
    Zama D; Cocchi I; Masetti R; Specchia F; Alvisi P; Gambineri E; Lima M; Pession A
    Ital J Pediatr; 2014 Oct; 40():68. PubMed ID: 25326164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.